Intriguingly, inhibition of MAPK signaling in BRAF-mutant thyroid cells resulted in translocation of YAP to the nucleus and activation of its transcriptional output, suggesting that it may play a role in orchestrating adaptive responses to the inhibition of the tumor driver. The gene discussed is BRAF; the disease is neoplasm.